Guild welcomes latest round of price disclosure

It says pharmacy has played its part in making medicine more affordable

The latest round of price disclosure cuts — worth $390 million in total — are contributing to a “very good outcome for all Australians”, the Pharmacy Guild says.   

Health costs

The October cycle of price reductions have affected 175 medicine brands, covering 15 drugs, including pregabalin and ezetimibe/simvastatin.

The Federal Government publicly announced the reductions on Monday, linking them to new PBS listings for lung cancer and leukaemia drugs and heralding “cheaper medicine ... for more than 500,000 patients”.